Citation: Kuo-Ting Ho, Chih-Ping Hsia, Chien-Ning Huang, Yih-Hsin Chang, Yao Lin, Ming-Yuh Shiau. Association between resistin promoter -420C>G polymorphisms and producing ability with type 2 diabetes mellitus[J]. AIMS Allergy and Immunology, 2017, 1(4): 181-193. doi: 10.3934/Allergy.2017.4.181
[1] | Saltiel AR (2001) New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104: 517–529. doi: 10.1016/S0092-8674(01)00239-2 |
[2] | Friedman JM (2000) Obesity in the new millennium. Nature 404: 632–634. doi: 10.1038/35007504 |
[3] | Spiegelman BM, Flier JS (2000) Obesity and the regulation of energy balance. Cell 104: 531–543. |
[4] | Halaas JL, Gajiwala KS, Maffei M, et al. (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269: 543–546. doi: 10.1126/science.7624777 |
[5] | Halaas JL, Boozer C, Blair-West J, et al. (1997) Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 94: 8878–8883. doi: 10.1073/pnas.94.16.8878 |
[6] | Cho YM, Youn BS, Chung SS, et al. (2004) Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 47: 559–565. doi: 10.1007/s00125-003-1319-x |
[7] | Steppan CM, EJ Brown, Wright CM, et al. (2001) A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 98: 502–506. doi: 10.1073/pnas.98.2.502 |
[8] | Fujinami A, Obayashi H, Ohta K, et al. (2004) Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta 339: 57–63. doi: 10.1016/j.cccn.2003.09.009 |
[9] | Silha JV, Krsek M, Skrha JV, et al. (2003) Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 149: 331–335. doi: 10.1530/eje.0.1490331 |
[10] | Azuma K, Katsukawa F, Oguchi S, et al. (2003) Correlation between serum resistin level and adiposity in obese individuals. Obes Res 11: 997–1001. doi: 10.1038/oby.2003.137 |
[11] | Steppan CM, Bailey ST, Bhat S, et al. (2001) The hormone resistin links obesity to diabetes. Nature 409: 307–312. doi: 10.1038/35053000 |
[12] | ED Muse, Obici S, Bhanot S, et al. (2004) Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 114: 232–239. doi: 10.1172/JCI200421270 |
[13] | Youn BS, Yu KY, Park HJ, et al. (2004) Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocr Metab 89: 150–156. |
[14] | Pizzuti A, Argiolas A, Di PR, et al. (2002) An ATG repeat in the 3'-untranslated region of the human resistin gene is associated with a decreased risk of insulin resistance. J Clin Endocr Metab 87: 4403–4406. doi: 10.1210/jc.2002-020096 |
[15] | Engert JC, Vohl MC, Williams SM, et al. (2002) 5' flanking variants of resistin are associated with obesity. Diabetes 51: 1629–1634. doi: 10.2337/diabetes.51.5.1629 |
[16] | Smith SR, Bai F, Charbonneau C, et al. (2003) A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 52: 1611–1618. doi: 10.2337/diabetes.52.7.1611 |
[17] | Conneely KN, Silander K, Scott LJ, et al. (2004) Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects. Diabetologia 47: 1782–1788. doi: 10.1007/s00125-004-1537-x |
[18] | Xita N, Georgiou I, Tsatsoulis A, et al. (2004) A polymorphism in the resistin gene promoter is associated with body mass index in women with polycystic ovary syndrome. Fertil Steril 82: 1466–1467. |
[19] | Mattevi VS, Zembrzuski VM, Hutz MH (2004) A resistin gene polymorphism is associated with body mass index in women. Hum Genet 115: 208–212. |
[20] | Ho KT, Shiau MY, Chang YH, et al. (2010) Association of IL-4 promoter polymorphisms in Taiwanese patients with type 2 diabetes mellitus. Metabolism 59: 1717–1722. doi: 10.1016/j.metabol.2010.04.010 |
[21] | Chang YH, Huang CN, Shiau MY (2012) Association of IL-4 receptor gene polymorphisms with high density lipoprotein cholesterol. Cytokine 59: 309–312. doi: 10.1016/j.cyto.2012.04.023 |
[22] | Osawa H, Yamada K, Onuma H, et al. (2004) The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet 75: 678–686. doi: 10.1086/424761 |
[23] | Ochi M, Osawa H, Hirota Y, et al. (2007) Frequency of the G/G genotype of resistin single nucleotide polymorphism at -420 appears to be increased in younger-onset type 2 diabetes. Diabetes 56: 2834–2838. doi: 10.2337/db06-1157 |
[24] | Xu JY, Sham PC, Xu A, et al. (2007) Resistin gene polymorphisms and progression of glycaemia in southern Chinese: a 5-year prospective study. Clin Endocrinol 66: 211–217. doi: 10.1111/j.1365-2265.2006.02710.x |
[25] | Hivert MF, Manning AK, McAteer JB, et al. (2009) Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham offspring study. Diabetes 58: 750–756. doi: 10.2337/db08-1339 |
[26] | Wen Y, Lu P, Dai L (2013) Association between resistin gene -420 C/G polymorphism and the risk of type 2 diabetes mellitus: a meta-analysis. Acta Diabetol 50: 267–272. doi: 10.1007/s00592-010-0247-8 |
[27] | Tan MS, Chang SY, Chang DM, et al. (2003) Association of resistin gene 3'-untranslated region +62G-->A polymorphism with type 2 diabetes and hypertension in a Chinese population. J Clin Endocr Metab 88: 1258–1263. doi: 10.1210/jc.2002-021453 |
[28] | Chi S, Lan C, Zhang S, et al. (2009) Association of -394C>G and -420C>G polymorphisms in the RETN gene with T2DM and CHD and a new potential SNP might be exist in exon 3 of RETN gene in Chinese. Mol Cell Biochem 330: 31–38. |
[29] | Chen BH, Song YQ, Ding EL, et al. (2010) Association of resistin promoter polymorphisms with plasma resistin levels and type 2 diabetes in women and men. Int J Mol Epidemiol Gene 1: 167–174. |
[30] | Tsukahara T, Nakashima E, Watarai A, et al. (2009) Polymorphism in resistin promoter region at -420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients. Diabetes Res Clin Pr 84: 179–186. |
[31] | Osawa H, Tabara Y, Kawamoto R, et al. (2009) PPARgamma Pro12Ala Pro/Pro and resistin SNP-420 G/G genotypes are synergistically associated with plasma resistin in the Japanese general population. Clin Endocrinol 71: 341–345. doi: 10.1111/j.1365-2265.2008.03465.x |
[32] | Osawa H, Onuma H, Ochi M, et al. (2005) Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes. Biochem Bioph Res Co 335: 596–602. |
[33] | Shiau MY, Wu CY, Huang CN, et al. (2003) Analysis of TNF-α G-238A and G-308A promoter polymorphism in Taiwanese patient with type 2 diabetes mellitus. Tissue Antigens 61: 393–397. doi: 10.1034/j.1399-0039.2003.00059.x |
[34] | Shiau MY, Huang CN, Liao JH, et al. (2004) Missense mutations in the human insulin promoter factor-1 gene are not a common cause of type 2 diabetes mellitus in Taiwanese. J Endocrinol Invest 27: 1076–1080. doi: 10.1007/BF03345313 |
[35] | Chang YH, Huang CN, Lee YL, et al. (2004) The C-174G Promoter polymorphism of the IL-6 gene that affects insulin sensitivity in Caucasians is not involved in the pathogenesis of Taiwanese type 2 diabetes mellitus. Eur Cytokine Netw 15: 117–119. |
[36] | Shiau MY, Huang CN, Wu CY, et al. (2005) Association of IL-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus. Hum Immunol 66: 1258–1263. doi: 10.1016/j.humimm.2005.05.001 |
[37] | Osawa H, Tabara Y, Kawamoto R, et al. (2007) Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population. Diabetes Care 30: 1501–1506. doi: 10.2337/dc06-1936 |
[38] | Azuma K, Oguchi S, Matsubara Y, et al. (2004) Novel resistin promoter polymorphisms: association with serum resistin level in Japanese obese individuals. Horm Metab Res 36: 564–570. doi: 10.1055/s-2004-825762 |
[39] | Suriyaprom K, Phonrat B, Namjuntra P, et al. (2009) The +299(G>A) resistin gene polymorphism and susceptibility to type 2 diabetes in Thais. J Clin Biochem Nutr 44: 104–110. doi: 10.3164/jcbn.08-224 |